First Drug Targets Root Cause of Rare Kidney Disease
A new medication just became the first therapy to directly target the damaged cells causing a serious kidney disease with no approved treatments. The breakthrough offers real hope for patients with FSGS, a rare condition that often leads to kidney failure.